Dapagliflozin Propanediol Monohydrate
Therapeutic Category
- Anti-diabetic
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Dapagliflozin as known from Brand Name Farxiga, is a sodium-glucose cotransporter 2 (sglt2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Dapagliflozin Propanediol Monohydrate with CAS# 461432-26-8. We are a leading exporter of Dapagliflozin Propanediol Monohydrate with CAS# 461432-26-8. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading API manufacturer & supplier of Dapagliflozin Propanediol Monohydrate with CAS# 461432-26-8. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File(DMF). Our manufacturing plant at Surat has accreditation by US-FDA, EDQM , EMA , ANVISA, KFDA, MOH IRAN, Health Canada & Russian Authorities.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.